This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| american | NORP | 1 | π π π§² |
| announce fiscal year 2025 | ORG | 1 | π π π§² |
| brazil | GPE | 1 | π π π§² |
| chiesi farmaceutici spa | ORG | 1 | π π π§² |
| company | ORG | 1 | π π π§² |
| elfabrio | PERSON | 1 | π π π§² |
| fda | ORG | 1 | π π π§² |
| food and drug administration | ORG | 1 | π π π§² |
| gaucher | PERSON | 1 | π π π§² |
| israel | GPE | 1 | π π π§² |
| lifesci advisors | PERSON | 1 | π π π§² |
| mike moyer | PERSON | 1 | π π π§² |
| nyse | ORG | 1 | π π π§² |
| pfizer inc | ORG | 1 | π π π§² |
| protalix | FAC | 1 | π π π§² |
| protalix biotherapeutics | ORG | 1 | π π π§² |
| protalix biotherapeutics inc | ORG | 1 | π π π§² |
| prx115 | PERSON | 1 | π π π§² |
| prx119 | ORG | 1 | π π π§² |
| share to x company | PRODUCT | 1 | π π π§² |
| share to x share | PRODUCT | 1 | π π π§² |
| source protalix biotherapeutics | PERSON | 1 | π π π§² |
| u.s. | GPE | 1 | π π π§² |
| webcast details | PERSON | 1 | π π π§² |
| webcast link | PERSON | 1 | π π π§² |
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 100.00 | π π° π§² |
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-03-11 10:50:00+00 | Business |
|
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026 | Analyze | Protalix BioTherapeutics, Inc. | π neutral | 0.1358 |